Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
130 studies found for:    Open Studies | "Pulmonary Fibrosis"
Show Display Options
Rank Status Study
21 Recruiting Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Cotrimoxazole;   Drug: Placebo
22 Recruiting A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: KD025;   Drug: Standard of Care
23 Unknown  Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis;   Interstitial Lung Disease;   Pulmonary Hypertension
Intervention: Drug: sildenafil
24 Recruiting Safety and Tolerability Study in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis;   IPF
Interventions: Drug: tipelukast;   Drug: Placebo
25 Unknown  Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis
Intervention:
26 Recruiting Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: ART-123;   Drug: Placebo
27 Recruiting Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: FG-3019;   Drug: Placebo
28 Recruiting A Safety and Tolerability Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Pirfenidone;   Drug: Vismodegib
29 Recruiting Explanted Lung Tissues With Pulmonary Fibrosis
Condition: Pulmonary Fibrosis
Intervention:
30 Unknown  Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis
Conditions: Pulmonary Fibrosis;   Pulmonary Hypertension
Intervention: Drug: Iloprost inhalation
31 Recruiting Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab
Condition: Pulmonary Fibrosis
Interventions: Drug: Bevacizumab;   Drug: Dexamethasone
32 Recruiting Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis
Condition: Pulmonary Fibrosis
Intervention: Drug: CC-90001
33 Recruiting A Study on Radiation-induced Pulmonary Fibrosis Treated With Clinical Grade Umbilical Cord Mesenchymal Stem Cells
Condition: Post-radiotherapy Pulmonary Fibrosis
Intervention: Biological: clinical grade umbilical cord mesenchymal stem cells
34 Recruiting Pulmonary Fibrosis Foundation Patient Registry
Conditions: Interstitial Lung Disease (ILD);   Idiopathic Pulmonary Fibrosis (IPF)
Intervention:
35 Recruiting Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Pulmonary Fibrosis
Intervention:
36 Recruiting Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Pulmonary Fibrosis
Intervention:
37 Recruiting Early Diagnosis of Pulmonary Fibrosis - Diagnostic Delay
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
38 Unknown  Idiopathic Pulmonary Fibrosis Registry for Future Studies
Conditions: Lung Disease, Interstitial;   Idiopathic Pulmonary Fibrosis
Intervention:
39 Recruiting Early Diagnosis of Pulmonary Fibrosis - Use of Biomarkers in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
40 Recruiting Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Behavioral: Physical exercise training;   Behavioral: Cognitive exercise training

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years